Cormorant Global Healthcare Master Fund, LP's Net Worth
$0
Who is Cormorant Global Healthcare Master Fund, LP?
Cormorant Global Healthcare Master Fund, LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Corbus Pharmaceuticals Holdings, Inc., Vigil Neuroscience, Inc., Prometheus Biosciences, Inc., Ambrx Biopharma, Inc., Design Therapeutics, Inc., Kezar Life Sciences, Inc., Icosavax, Inc., Kiniksa Pharmaceuticals, Ltd., Ventyx Biosciences, Inc., Axonics Modulation Technologies, Inc., Tyra Biosciences, Inc., Erasca, Inc., Monte Rosa Therapeutics, Inc., Verve Therapeutics, Inc., Aerovate Therapeutics, Inc., Avidity Biosciences, Inc., Apellis Pharmaceuticals, Inc., Immuneering Corp, Pyxis Oncology, Inc., Elevation Oncology, Inc., PROTEOSTASIS THERAPEUTICS, INC., BioAtla, Inc., Ambrx Biopharma Inc., Biomea Fusion, Inc., Rain Therapeutics Inc., Akouos, Inc., Cellectar Biosciences, Inc., Olema Pharmaceuticals, Inc., Clearside Biomedical, Inc., GreenLight Biosciences Holdings, PBC, CONSTELLATION PHARMACEUTICALS INC, Atea Pharmaceuticals, Inc., MoonLake Immunotherapeutics, and EyePoint Pharmaceuticals, Inc..
SEC CIK
Cormorant Global Healthcare Master Fund, LP's CIK is 0001618442
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Snapshot price: $50.04
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +37.29% | 550K |
$42.41 | $23,327,559.60 | 2.02M |
Mar 7 - Mar 8
| |||
Form 4
| +103.45% | 750K |
$19.00 | $14,250,000.00 | 1.48M |
Feb 2
| |||
Form 4
| +63.89% | 282.63K |
$32.24 | $9,111,940.74 | 725K |
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vigil Neuroscience, Inc. (VIGL) Snapshot price: $3.53
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 616.79K |
—
|
—
| 616.79K |
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prometheus Biosciences, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.22M |
$19.00 |
—
| 2.22M |
Mar 16
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ambrx Biopharma, Inc. (AMAM) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.17% | 1.31M |
$6.99 | $9,139,541.93 | 11.23M |
Oct 23
| |||
| No matching records found | |||||||||
Design Therapeutics, Inc. (DSGN) Snapshot price: $4.67
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.11M |
$20.00 |
—
| 5.11M |
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||